Allianz Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Sell
2,500
-1,300
-34% -$834K ﹤0.01% 1653
2025
Q4
$2.57M Buy
3,800
+1,000
+36% +$681K ﹤0.01% 1453
2025
Q3
$1.79M Buy
2,800
+1,100
+65% +$668K ﹤0.01% 1540
2025
Q2
$912K Sell
1,700
-1,800
-51% -$861K ﹤0.01% 1690
2025
Q1
$1.47M Buy
3,500
+2,600
+289% +$1.13M ﹤0.01% 1582
2024
Q4
$372K Buy
+900
New +$395K ﹤0.01% 1950
2024
Q3
Sell
-800
Closed -$390K 2228
2024
Q2
$390K Buy
+800
New +$402K ﹤0.01% 1909
2024
Q1
Sell
-1,200
Closed -$666K 2151
2023
Q4
$666K Sell
1,200
-3,300
-73% -$1.55M ﹤0.01% 1755
2023
Q3
$1.97M Buy
4,500
+3,900
+650% +$1.94M ﹤0.01% 1446
2023
Q2
$301K Sell
600
-2,600
-81% -$1.25M ﹤0.01% 1836
2023
Q1
$1.6M Buy
+3,200
New +$1.53M ﹤0.01% 1474
2022
Q2
Sell
-500
Closed -$274K 2321
2022
Q1
$274K Sell
500
-2,400
-83% -$1.26M ﹤0.01% 2238
2021
Q4
$1.91M Sell
2,900
-1,100
-28% -$691K ﹤0.01% 1632
2021
Q3
$2.49M Buy
4,000
+2,000
+100% +$1.34M ﹤0.01% 1576
2021
Q2
$1.26M Buy
+2,000
New +$1.1M ﹤0.01% 1645
2020
Q3
Sell
-15,900
Closed -$5.25M 2107
2020
Q2
$5.25M Buy
15,900
+14,300
+894% +$4.14M 0.01% 1189
2020
Q1
$388K Sell
1,600
-1,300
-45% -$339K ﹤0.01% 2145
2019
Q4
$757K Sell
2,900
-400
-12% -$105K ﹤0.01% 2294
2019
Q3
$897K Buy
3,300
+800
+32% +$223K ﹤0.01% 2167
2019
Q2
$688K Buy
+2,500
New +$616K ﹤0.01% 2257

Other funds holding IDXX

Allianz Asset Management's IDXX Position: Q1 2026 in Review

Allianz Asset Management reduced its Idexx Laboratories (IDXX) stake by 4% in Q1 2026, selling an estimated $5.55M and leaving 207,403 shares worth $117M. The position accounts for 0.12% of the portfolio, ranked #165.

Allianz Asset Management first reported a position in IDXX in Q4 2013 and has held it in 42 quarters since. The position peaked at $199M in Q2 2021. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Allianz Asset Management held 207,403 shares of Idexx Laboratories worth $117M as of Q1 2026.
  • Allianz Asset Management sold 8,654 Idexx Laboratories shares in Q1 2026, an estimated $5.55M.
  • Idexx Laboratories made up 0.12% of Allianz Asset Management's portfolio in Q1 2026, its #165 holding.
  • Allianz Asset Management first reported a position in Idexx Laboratories in Q4 2013 and has held it in 42 quarters since.
  • Allianz Asset Management's Idexx Laboratories position peaked at $199M in Q2 2021.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.